Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ORICORIC
23 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ORIC PHARMACEUTICALS INC

CITADEL ADVISORS LLC holds 2.6M shares of ORIC (ORIC PHARMACEUTICALS INC), worth $28.1M as of 2026-Q2. The position was increased (+7.1% shares). ORIC represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$28.1M

Current Shares

2.6M

Total Value Change

+$27.9M

Total Shares Change

+2.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.6M
+7.1%
$28.1M0.0%$10.83
31
2026-Q1
Decreased
2.4M
-0.5%
$30.7M0.0%$13.51
0
2025-Q4
Increased
2.4M
+103.2%
$19.9M0.0%$8.08
46
2025-Q3
Decreased
1.2M
-14.6%
$14.4M0.0%$11.62
0
2025-Q2
Increased
1.4M
+174.0%
$14.2M0.0%$10.31
45
2025-Q1
Increased
511,889
+1305.3%
$2.9M0.0%$6.14
42
2024-Q4
Increased
36,426
+531.6%
$293,9580.0%$8.17
38
2024-Q3
New
5,767
-
$59,1120.0%$10.65
32
2023-Q4
Exited
0
-100.0%
$00.0%$9.20
0
2023-Q3
Increased
145,007
+85.3%
$877,2920.0%$6.05
39
2023-Q2
Decreased
78,275
-34.5%
$607,4140.0%$7.55
0
2023-Q1
Increased
119,603
+52.1%
$681,7370.0%$5.43
34
2022-Q4
Increased
78,633
+532.3%
$463,1480.0%$5.89
39
2022-Q3
Decreased
12,437
-93.8%
$40,0000.0%$3.24
0
2022-Q2
Decreased
200,387
-13.1%
$898,0000.0%$4.50
0
2022-Q1
New
230,687
-
$1.2M0.0%$5.44
35
2021-Q4
Exited
0
-100.0%
$00.0%$15.59
0
2021-Q3
Decreased
15,377
-20.4%
$322,0000.0%$20.55
0
2021-Q2
New
19,315
-
$342,0000.0%$17.37
33
2021-Q1
Exited
0
-100.0%
$00.0%$23.67
0
2020-Q4
Decreased
40,435
-39.8%
$1.4M0.0%$36.67
0
2020-Q3
Increased
67,207
+883.9%
$1.7M0.0%$23.12
41
2020-Q2
New
6,831
-
$230,0000.0%$34.19
32

Other major holders of ORIC: VIKING GLOBAL INVESTORS LP, BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used